Cargando…

Fast urinary screening of oligosaccharidoses by MALDI-TOF/TOF mass spectrometry

BACKGROUND: Oligosaccharidoses, which belong to the lysosomal storage diseases, are inherited metabolic disorders due to the absence or the loss of function of one of the enzymes involved in the catabolic pathway of glycoproteins and indirectly of glycosphingolipids. This enzymatic deficiency typica...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonesso, Laurent, Piraud, Monique, Caruba, Céline, Van Obberghen, Emmanuel, Mengual, Raymond, Hinault, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922009/
https://www.ncbi.nlm.nih.gov/pubmed/24502792
http://dx.doi.org/10.1186/1750-1172-9-19
_version_ 1782303394388508672
author Bonesso, Laurent
Piraud, Monique
Caruba, Céline
Van Obberghen, Emmanuel
Mengual, Raymond
Hinault, Charlotte
author_facet Bonesso, Laurent
Piraud, Monique
Caruba, Céline
Van Obberghen, Emmanuel
Mengual, Raymond
Hinault, Charlotte
author_sort Bonesso, Laurent
collection PubMed
description BACKGROUND: Oligosaccharidoses, which belong to the lysosomal storage diseases, are inherited metabolic disorders due to the absence or the loss of function of one of the enzymes involved in the catabolic pathway of glycoproteins and indirectly of glycosphingolipids. This enzymatic deficiency typically results in the abnormal accumulation of uncompletely degraded oligosaccharides in the urine. Since the clinical features of many of these disorders are not specific for a single enzyme deficiency, unambiguous screening is critical to limit the number of costly enzyme assays which otherwise must be performed. METHODS: Here we provide evidence for the advantages of using a MALDI-TOF/TOF (matrix-assisted laser desorption ionization time-of-flight) mass spectrometric (MS) method for screening oligosaccharidoses. Urine samples from previously diagnosed patients or from unaffected subjects were randomly divided into a training set and a blind testing set. Samples were directly analyzed without prior treatment. RESULTS: The characteristic MS and MS/MS molecular profiles obtained allowed us to identify fucosidosis, aspartylglucosaminuria, GM1 gangliosidosis, Sandhoff disease, α-mannosidosis, sialidosis and mucolipidoses type II and III. CONCLUSIONS: This method, which is easily run in less than 30 minutes, is performed in a single step, and is sensitive and specific. Invaluable for clinical chemistry purposes this MALDI-TOF/TOF mass spectrometry procedure is semi-automatizable and suitable for the urinary screening of oligosacharidoses.
format Online
Article
Text
id pubmed-3922009
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39220092014-02-13 Fast urinary screening of oligosaccharidoses by MALDI-TOF/TOF mass spectrometry Bonesso, Laurent Piraud, Monique Caruba, Céline Van Obberghen, Emmanuel Mengual, Raymond Hinault, Charlotte Orphanet J Rare Dis Research BACKGROUND: Oligosaccharidoses, which belong to the lysosomal storage diseases, are inherited metabolic disorders due to the absence or the loss of function of one of the enzymes involved in the catabolic pathway of glycoproteins and indirectly of glycosphingolipids. This enzymatic deficiency typically results in the abnormal accumulation of uncompletely degraded oligosaccharides in the urine. Since the clinical features of many of these disorders are not specific for a single enzyme deficiency, unambiguous screening is critical to limit the number of costly enzyme assays which otherwise must be performed. METHODS: Here we provide evidence for the advantages of using a MALDI-TOF/TOF (matrix-assisted laser desorption ionization time-of-flight) mass spectrometric (MS) method for screening oligosaccharidoses. Urine samples from previously diagnosed patients or from unaffected subjects were randomly divided into a training set and a blind testing set. Samples were directly analyzed without prior treatment. RESULTS: The characteristic MS and MS/MS molecular profiles obtained allowed us to identify fucosidosis, aspartylglucosaminuria, GM1 gangliosidosis, Sandhoff disease, α-mannosidosis, sialidosis and mucolipidoses type II and III. CONCLUSIONS: This method, which is easily run in less than 30 minutes, is performed in a single step, and is sensitive and specific. Invaluable for clinical chemistry purposes this MALDI-TOF/TOF mass spectrometry procedure is semi-automatizable and suitable for the urinary screening of oligosacharidoses. BioMed Central 2014-02-06 /pmc/articles/PMC3922009/ /pubmed/24502792 http://dx.doi.org/10.1186/1750-1172-9-19 Text en Copyright © 2014 Bonesso et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Research
Bonesso, Laurent
Piraud, Monique
Caruba, Céline
Van Obberghen, Emmanuel
Mengual, Raymond
Hinault, Charlotte
Fast urinary screening of oligosaccharidoses by MALDI-TOF/TOF mass spectrometry
title Fast urinary screening of oligosaccharidoses by MALDI-TOF/TOF mass spectrometry
title_full Fast urinary screening of oligosaccharidoses by MALDI-TOF/TOF mass spectrometry
title_fullStr Fast urinary screening of oligosaccharidoses by MALDI-TOF/TOF mass spectrometry
title_full_unstemmed Fast urinary screening of oligosaccharidoses by MALDI-TOF/TOF mass spectrometry
title_short Fast urinary screening of oligosaccharidoses by MALDI-TOF/TOF mass spectrometry
title_sort fast urinary screening of oligosaccharidoses by maldi-tof/tof mass spectrometry
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922009/
https://www.ncbi.nlm.nih.gov/pubmed/24502792
http://dx.doi.org/10.1186/1750-1172-9-19
work_keys_str_mv AT bonessolaurent fasturinaryscreeningofoligosaccharidosesbymalditoftofmassspectrometry
AT piraudmonique fasturinaryscreeningofoligosaccharidosesbymalditoftofmassspectrometry
AT carubaceline fasturinaryscreeningofoligosaccharidosesbymalditoftofmassspectrometry
AT vanobberghenemmanuel fasturinaryscreeningofoligosaccharidosesbymalditoftofmassspectrometry
AT mengualraymond fasturinaryscreeningofoligosaccharidosesbymalditoftofmassspectrometry
AT hinaultcharlotte fasturinaryscreeningofoligosaccharidosesbymalditoftofmassspectrometry